VHL and nonpapillary renal cell carcinoma: In the case of ccRCC, however, VHL is the only consistent truncal mutation, which has only recently become targetable through its downstream HIF effectors, demonstrating the need to delve deeper into other processes contributing to ITH [1, 11, 12].